StonvexLoading…
StonvexStonvexStonvexCore line items from GBCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $101.07M | $94.01M | $88.55M | $82.85M |
Operating Income | $290.25M | $226.30M | $267.61M | $370.28M |
Net Income | $239.03M | $190.14M | $222.93M | $303.20M |
EPS (Diluted) | $1.99 | $1.68 | $2.01 | $2.74 |
Total Assets | $31.98B | $27.90B | $27.74B | $26.64B |
Total Liabilities | $27.76B | $24.68B | $24.72B | $23.79B |
Cash & Equivalents | $1.24B | $848.41M | $1.35B | $402.00M |
Free Cash Flow OCF − CapEx | $347.55M | $209.76M | $451.18M | $436.90M |
Shares Outstanding | 129.97M | 113.40M | 110.89M | 110.78M |